Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Skin problems are common and important signs of eating disorders and treating the eating disorder can improve these skin conditions.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Spironolactone plus finasteride reduces hirsutism more effectively.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Disrupting Acvr1b in mice causes severe hair loss and thicker skin.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.